Branding Clinical Research Pharma Companies 
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 17, 2024
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
Pharmaceutical Technology
FEBRUARY 24, 2023
A leaked draft (see below) of the legislation, whose final version will be published next month, proposes reducing market exclusivity time by one year for most branded drugs, although it would extend exclusivity for certain drugs for unmet needs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MARCH 3, 2025
Digital advertising campaigns allow pharmaceutical brands to connect with their audiences at critical moments in the healthcare journey. How Digital Ads Are Changing Pharma Marketing Precision Targeting : AI and data analytics allow ads to be shown to HCPs based on specialty, prescribing behavior, and practice location.
Pharma Marketing Network
MARCH 3, 2025
Digital advertising campaigns allow pharmaceutical brands to connect with their audiences at critical moments in the healthcare journey. How Digital Ads Are Changing Pharma Marketing Precision Targeting : AI and data analytics allow ads to be shown to HCPs based on specialty, prescribing behavior, and practice location.
Pharma Marketing Network
NOVEMBER 7, 2024
With a competitive landscape and ever-evolving regulations, having effective pharmaceutical marketing strategies is crucial for pharma companies looking to stand out. Offer Solutions, Not Just Products : Focus on how your brand can make their work easier or their patients’ lives better. Tip: Authenticity is key.
Intouch Solutions
JUNE 30, 2022
Pharma companies in the metaverse? Other companies like Healium are doing the same. But brands are increasingly going to have to address this unfamiliarity, and normalize therapeutics that aren’t just made out of cellulose and proteins. – made a purchase inside a metaverse.
The Pharma Data
DECEMBER 17, 2020
Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. AB2 Bio – Swiss pharma company AB2 Bio Ltd.
Expert insights. Personalized for you.
189 
Let's personalize your content